Combined treatment using peripheral nerve graft and FGF-1: changes to the glial environment and differential macrophage reaction in a complete transected spinal cord

Neurosci Lett. 2008 Mar 15;433(3):163-9. doi: 10.1016/j.neulet.2007.11.067. Epub 2007 Dec 15.

Abstract

We used a complete spinal cord transection model in which the T8 spinal segment was removed to study the effect of combined treatment of peripheral nerve graft and application of FGF-1 on the glial environment. The combined treatment resulted in reduced astrocytic glial scarring, reactive macrophage gliosis, and inhibitory proteoglycan in the back-degenerated white matter tract. While the macrophage activities in the back-degenerative tract were down-regulated, those in the grafted peripheral nerves and in the distal Wallerian degenerative tracts were not. We concluded that the combined treatment changed the glial environment in the back-degenerative tract, and differentially regulated the macrophage activities in the system, in favor of CNS regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / physiology
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Disease Models, Animal
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Female
  • Fibroblast Growth Factor 1 / pharmacology*
  • Fibroblast Growth Factor 1 / therapeutic use
  • Glial Fibrillary Acidic Protein / metabolism
  • Gliosis / etiology
  • Gliosis / physiopathology
  • Gliosis / prevention & control*
  • Graft Survival / drug effects
  • Graft Survival / physiology
  • Macrophages / drug effects
  • Macrophages / physiology
  • Nerve Regeneration / drug effects
  • Nerve Regeneration / physiology
  • Neural Pathways / drug effects
  • Neural Pathways / pathology
  • Neural Pathways / physiopathology
  • Neuroglia / drug effects
  • Neuroglia / physiology
  • Peripheral Nerves / cytology
  • Peripheral Nerves / physiology
  • Peripheral Nerves / transplantation*
  • Proteoglycans / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Cord Injuries / drug therapy*
  • Spinal Cord Injuries / physiopathology
  • Spinal Cord Injuries / surgery*
  • Tissue Transplantation / methods*
  • Treatment Outcome
  • Wallerian Degeneration / etiology
  • Wallerian Degeneration / physiopathology
  • Wallerian Degeneration / prevention & control

Substances

  • Biomarkers
  • Glial Fibrillary Acidic Protein
  • Proteoglycans
  • Fibroblast Growth Factor 1